Jamie Clark
Stock Analyst at Rothschild & Co
(2.05)
# 3,029
Out of 5,182 analysts
9
Total ratings
57.14%
Success rate
4.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Buy | $311 | $254.80 | +22.06% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $342 → $474 | $498.34 | -4.88% | 1 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $184 → $236 | $114.19 | +106.67% | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $173.89 | +4.66% | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $273.72 | +0.83% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $198.02 | -1.53% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $173.26 | +59.30% | 1 | Oct 14, 2024 |
West Pharmaceutical Services
Sep 15, 2025
Initiates: Buy
Price Target: $311
Current: $254.80
Upside: +22.06%
Medpace Holdings
Sep 3, 2025
Downgrades: Neutral
Price Target: $342 → $474
Current: $498.34
Upside: -4.88%
ICON Public Limited Company
Sep 3, 2025
Upgrades: Buy
Price Target: $184 → $236
Current: $114.19
Upside: +106.67%
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $173.89
Upside: +4.66%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $273.72
Upside: +0.83%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $198.02
Upside: -1.53%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $173.26
Upside: +59.30%